AzTrials
AzTrials

Cleft Lip and PalateNCT05081258

Influence of Presurgical Orthodontic Molding on the Growth of Newborns With Unilateral Cleft Lip Palate

A study testing passive Alveolar Molding and Nasoalveolar Molding in people with Cleft Lip and Palate and Unilateral Cleft Lip, run by University of Erlangen-Nürnberg at 1 site in Germany.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

Orofacial clefts are the second most common birth deformity and vary in etiology and phenotype, e.g. isolated cleft palate, cleft lip or cleft lip palate. Especially newborns with unilateral complete cleft lip and palate (UCLP) present severe facial asymmetries auch as a broad and flat ala of the nose, a deviation of… Read more about this study

Who is it for?
Ages 1 day to 2 yearsHealthy volunteers can take part
Conditions the study is for
Cleft Lip and Palate, Unilateral Cleft Lip
What is being tested?
passive Alveolar Molding and Nasoalveolar Molding
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
34 participants
Where
1 siteGermany
Study dates
1 May 2022to 1 Nov 2026
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 2 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • newborns/infants with non-syndromal (ns) unilateral cleft lip palate (UCLP)
  • signed informed consent by the parents or legal guardian

Who cannot join

  • newborns/infants with syndromal (s) unilateral cleft lip palate (UCLP)
  • insufficient adherence and compliance by the parents or legal guardian
  • withdrawal of informed consent by the parents or legal guardian

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Germany1 site, 1 recruiting
  • Department of Orthodontics and Orofacial Orthopedics, University Hospital of Erlangen-Nurnberg

    Erlangen, Bavaria, 91054

    Corinna Seidel, Dr., ++49-09131-85-45667, corinna.seidel@uk-erlangen.de

    Lina Gölz, Prof. Dr., ++49-09131-85-33643, lina.goelz@uk-erlangen.de

    Recruiting

Other trials in Germany

About this study

Official title: Influence of Presurgical Orthodontic Molding on the Growth of Newborns With Unilateral Cleft Lip Palate: a Prospective, Randomized, Clinical Trial

Orofacial clefts are the second most common birth deformity and vary in etiology and phenotype, e.g. isolated cleft palate, cleft lip or cleft lip palate. Especially newborns with unilateral complete cleft lip and palate (UCLP) present severe facial asymmetries auch as a broad and flat ala of the nose, a deviation of the columella and the philtrum to the non cleft side. Since postnatal asymmetries can even remain after surgical lip closure in a alleviated shape, therapeutic presurgical orthodontic approaches to improve symmetrie of the nose and to achieve ideal conditions for lip surgery are essential.

Presurgical orthodontic treatment for newborns with UCLP start within the first days after birth to separate oral and nasal cavitiy, to improve breathing and feeding and to regulate growth of the maxillary segments using passive appliances (passive Alveolar Molding (pAM)). An advanced and widely spread concept is the Nasoalveolar Molding (NAM) by Grayson, which was first introduced in 1993 as a palate plate combined with a nasal stent as a non-invasive presurgical appliance to stimulate growth of the nose and use the postnatal potential to modulate the nasal cartilage. The aim of the NAM therapy is to reduce nasal width, to reduce deviation of the columella to the non cleft side and to increase nostril height. However, due to inhomogeneous study designs and results, so far only a slightly positive effect using NAM therapy could be detected and prospective, randomized clinical trials are necessary.

The aim of the study is to analyse and to compare the effects of pAM versus NAM treatment in newborns with UCLP in the first year of life. The following parameters will be analysed on defined study time points: nostril width, nasal morphology, cleft width, maxillary growth, statical and dynamical facial asymmetries and facial perception.

Being tested
passive Alveolar Molding, Nasoalveolar Molding
Keywords
passie Alveolar Molding, Nasoalveolar Molding, Maxillary Growth, Facial Asymmetry
Medical subject headings
Cleft Lip, Facial Asymmetry

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • passive Alveolar MoldingProcedure or surgery

    A passive palate plate (passive Alveolar Molding) will be inserted within the first week after birth. The pAM appliance will be modified on regular appointments and remain until surgical lip closure (6-7 months of life). After surgical lip closure, infants will receive a nostril retainer and the treatment with the pAM appliance will continue until palate closure (10-12 months of life).

  • Nasoalveolar MoldingProcedure or surgery

    A passive palate plate will be inserted within the first week after birth. A nasal stent will be added to the palate plate after one week (NAM appliance). The NAM appliance will be modified on regular appointments and remain until surgical lip closure (6-7 months of life). After surgical lip closure, infants will receive a nostril retainer and will be treated with a passive palate plate without nasal stent until palate closure (10-12 months of life).

Study groups in NCT05081258
Study groupRoleWhat they receive
NAM treatmentActive comparatorStudy Group: newborns with UCLP will be treated with a palate plate with nasal stent (Nasoalveolar Molding = NAM)
Receives: Procedure: Nasoalveolar Molding
pAM treatmentSham comparatorControl Group: newborns with UCLP will be treated with a palate plate without nasal stent (passive Alveolar Molding = pAM)
Receives: Procedure: passive Alveolar Molding

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Columella Deviation Angle

    The change of the Collumella Deviation Angle from Baseline until surgical lip closure. The change of the Columella Deviation Angle will be measured digitally using 3D-scanned models from the nose (scans and impressions from the nose) and defined anatomical points placed by four raters.

    Sbalc (lNc) = Subalar point on the cleft side Sbalnc (lNnc) = Subalar point on the non-cleft side SN = Subnasal point sn'c (mNc) = Subnasale' point Prn = Pronasal point

    CDA = Columella Deviation Angle = Angle (°) between the columella axis (connecting line between SN and Prn) and Subalar base line (connecting line between Sbalc and Sbalnc) on the cleft side

    Measured: From baseline (after birth) until surgical lip closure (6 - 7 months of life)

  2. Nostril Width on the cleft side

    The change of the Nostril Width on the cleft side from Baseline until surgical lip closure considering different time points. The change of the Nostril Width on the cleft side will be measured digitally using 3D-scanned models from the nose (scans and impressions from the nose) and defined anatomical points placed by four raters:

    Sbalc (lNc) = Subalar point on the cleft side Sbalnc (lNnc) = Subalar point on the non-cleft side SN = Subnasal point sn'c (mNc) = Subnasale' point Prn = Pronasal point NWc = Nostril Width on the cleft side = Distance (mm) of the connecting line between Sbalc and sn'c

    Measured: From baseline (after birth) until surgical lip closure (6 - 7 months of life)

Secondary outcomes (6)
  1. Nasal shape

    The change of the nasal shape from Baseline until one year after surgical palate closure considering different time points. The change of the nasal shape will be measured digitally using 3D-scanned models from the nose (scans and impressions from the nose) and defined anatomical points placed by four raters and used for distance (mm) measurements: Subalar point; Subnasal point; Lip Points; ala of the nose; cranial point of the nostril and medial point of the nostril.

    Measured: From baseline (after birth) until one year after surgical palate closure (24 months of life)

  2. Nasal symmetry

    The change of the nasal symmetry from Baseline until one year after surgical palate closure considering different time points. The change of the nasal symmetry will be measured digitally using 3D-scanned models from the nose (scans and impressions from the nose) and defined anatomical points placed by four raters and used for angle (°) measurements: Subalar point; Subnasal point; Lip Points; ala of the nose; cranial point of the nostril and medial point of the nostril.

    Measured: From baseline (after birth) until one year after surgical palate closure (24 months of life)

  3. Alveolar cleft width and transversal/sagittal maxillary growth

    The change of the anterior cleft width and transversal/sagittal maxillary growth from Baseline until one year after surgical palate closure considering different time points. The change of the alveolar cleft width and transversal/sagittal maxillary growth will be measured digitally using 3D-scanned models from the maxilla (impressions from the maxilla) and defined anatomical points placed by four raters and used for distance (mm) measurements:

    pole points; mesial/distal canine points; tuber points and incisal point.

    Measured: From baseline (after birth) until one year after surgical palate closure (24 months of life)

  4. Alveolar symmetry and rotation of alveolar segments

    The change of the alveolar symmetry and rotation of alveolar segments from Baseline until one year after surgical palate closure considering different time points. The change of the alveolar symmetry and rotation of alveolar segments will be measured digitally using 3D-scanned models from the maxilla (impressions from the maxilla) and defined anatomical points placed by four raters and used for angle (°) measurements:

    pole points; mesial/distal canine points; tuber points and incisal point.

    Measured: From baseline (after birth) until one year after surgical palate closure (24 months of life)

  5. Statistical and dynamical facial asymmetries

    The change of statical and dynamical facial asymmetries from Baseline until one year after surgical palate closure considering different time points. The statical and dynamical facial asymmetries will be measured digitally using 3D-scans of the face performed on 5 time points (1. rest position, 2. between 1 and 3, 3. maximal facial expression, 4. between 3 and 5, 5. final rest position). Defined anatomical an constucted points will be placed by four raters. Measurements will be performed by mirroring scans accordind to a reference plane. Asymmetries are the distances (mm) of the corresponding Points, which would be 0mm in perfect symmetry.

    The following points will be placed: S = Superciliar Point, Exocanthion; Endocanthion; Zygion; Glabella; Nasion; Pronasale; Subnasale; Pogonion; Subalare; Alare; Cheilion; Labrale superius; Labrale inferius; Crista philtri and Lip Points (median, lateral, corresponding points).

    Measured: From baseline (after birth) until one year after surgical palate closure (24 months of life)

  6. Facial perception

    Facial perception will be rated using 3 pictures photographs / processed photographs of each newborn with UCLP within the first weeks after birth, after insertion of first appliance and until surgical lip closure (without NAM appliance, with NAM appliance, without cleft processed using photoshop). The pictures will be rated from laypersons using a 10-point-rating scale ranging from 1 to 10.

    1 = highest attractiveness (greatest positive emotional valance) 10 = least attactiveness / Aversion (greatest negative emotional valence).

    Measured: From Baseline (after birth) until surgical lip closure (6-7 months of life)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Oct 2021
  2. Study start1 May 2022
  3. Primary completion1 Nov 2026 (estimated)
  4. Study completion1 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
prospective, longitudinal, randomized, clinical trial
Masking
None (open label)
Enrolment
34 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05081258
Sponsor's protocol ID
ER-pAM-NAM-UCLP-RCT
Status last verified
May 2022
First submitted
4 Aug 2021
Last updated
18 May 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in